ZNF254 Inhibitors
Chemical inhibitors of the protein ZNF254 act through various biochemical pathways to impede its function. Staurosporine and Sotrastaurin directly affect the protein by inhibiting the activity of kinases, which are enzymes crucial for the phosphorylation of proteins, including transcription factors like ZNF254. Phosphorylation is often required for the proper function and regulation of transcription factors, so by preventing this modification, these inhibitors disrupt ZNF254's ability to exert its role in gene expression. Triptolide takes a different approach by inhibiting the activation of transcription factors through the suppression of NF-kB, a protein complex that plays a key role in regulating the immune response to infection. Since ZNF254's activity can be contingent upon NF-kB mediated pathways, triptolide effectively diminishes ZNF254's functional capacity.
MG-132 and Bortezomib share a mechanism of inhibition by targeting the ubiquitin-proteasome pathway. This pathway is responsible for degrading misfolded or damaged proteins, which includes the regulatory proteins that control ZNF254 activity. By inhibiting the proteasome, these chemicals stabilize the proteins that would otherwise degrade and, as a consequence, prevent ZNF254 from functioning normally. Trichostatin A and 5-Azacytidine alter the chromatin structure and DNA methylation patterns, respectively, thereby affecting the ability of ZNF254 to access and bind to its DNA targets. Trichostatin A inhibits histone deacetylases, which can lead to a more open chromatin structure, whereas 5-Azacytidine reduces the methylation of DNA, a modification that often controls gene expression and the binding affinity of DNA-binding proteins. Leflunomide and Mitoxantrone disrupt the cell's replication machinery and, consequently, the conditions necessary for ZNF254 to engage with DNA effectively. Alvespimycin and Geldanamycin inhibit HSP90, a molecular chaperone involved in the proper folding and functioning of many proteins, including ZNF254. Without correctly folded structures, ZNF254 cannot fulfill its role in gene regulation. Lastly, Ibrutinib, although primarily recognized for its role in other areas, can indirectly modulate the function of ZNF254 by inhibiting kinase signaling pathways that ZNF254 may rely upon for its activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. As ZNF254 is a zinc finger protein potentially interacting with kinases for its functional conformation, Staurosporine inhibits those kinases, leading to functional inhibition of ZNF254. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide is known to inhibit transcription factors and NF-kB activation. ZNF254, as a transcription factor, requires activation that could be mediated by NF-kB; thus, triptolide inhibits ZNF254 by preventing its activation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a proteasome inhibitor that prevents the degradation of ubiquitinated proteins. By stabilizing proteins that regulate the activity of ZNF254, MG-132 indirectly inhibits the function of ZNF254 by preventing its regulatory proteins' degradation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is another proteasome inhibitor that impedes the degradation of proteins that control the activity of ZNF254. By maintaining the levels of these regulatory proteins, Bortezomib functionally inhibits ZNF254. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can alter chromatin structure and affect transcription factor access to DNA. ZNF254, as a transcription factor, may require specific chromatin conformations to bind DNA, so Trichostatin A inhibits ZNF254 by preventing these conformations. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine inhibits DNA methyltransferases, leading to hypomethylation of DNA. If ZNF254 binds preferentially to methylated DNA regions, the action of 5-Azacytidine would result in the functional inhibition of ZNF254 by altering its DNA binding affinity. | ||||||
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $83.00 | 5 | |
Leflunomide inhibits dihydroorotate dehydrogenase, affecting pyrimidine synthesis, which can influence cell proliferation and the activity of transcription factors. Hence, ZNF254 is functionally inhibited by leflunomide due to reduced proliferation signals. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone intercalates into DNA and inhibits topoisomerase II, which is necessary for DNA replication and transcription. By interfering with these processes, mitoxantrone functionally inhibits ZNF254 by preventing its interaction with DNA. | ||||||
17-DMAG | 467214-20-6 | sc-202005 | 1 mg | $205.00 | 8 | |
Alvespimycin is an HSP90 inhibitor, and HSP90 is involved in the correct folding of many proteins, including transcription factors. Inhibiting HSP90 leads to the functional inhibition of ZNF254 by disrupting its proper folding and function. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin also inhibits HSP90, which may be required for the maturation and function of ZNF254. By inhibiting HSP90, geldanamycin functionally inhibits ZNF254. | ||||||